BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

被引：0
|
作者：
Del Giudice, Ilaria [1 ]
Bonina, Silvia [1 ]
Marinelli, Marilisa [1 ]
Cafforio, Luciana [1 ]
Raponi, Sara [1 ]
Boldrini, Eloise [1 ]
Bonafede, Alexia [1 ]
Tavolaro, Simona [1 ]
Ilari, Caterina [1 ]
Messina, Monica [2 ]
Chiaretti, Sabina [1 ]
Mauro, Francesca Romana [1 ]
Piciocchi, Alfonso [3 ]
Orlando, Sonia Maria [3 ]
Rigolin, Gian Matteo [4 ]
Cuneo, Antonio [4 ]
Rossi, Davide [5 ]
Gaidano, Gianluca [5 ]
Guarini, Anna [6 ]
Foa, Robin [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, I-00185 Rome, Italy
[3] GIMEMA Fdn, GIMEMA Data Ctr, Rome, Italy
[4] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Hematol Sect, I-44100 Ferrara, Italy
[5] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy
[6] Univ Roma La Sapienza, I-00185 Rome, Italy
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone
    Marasca, Roberto
    Maffei, Rossana
    Martinelli, Silvia
    Fiorcari, Stefania
    Bulgarelli, Jenny
    Debbia, Giulia
    Rossi, Davide
    Rossi, Francesca Maria
    Rigolin, Gian Matteo
    Martinelli, Sara
    Gattei, Valter
    Del Poeta, Giovanni
    Laurenti, Luca
    Forconi, Francesco
    Montillo, Marco
    Gaidano, Gianluca
    Luppi, Mario
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (02) : 348 - 355
  • [42] BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL)
    Nasr, Amen Allah
    Fund, Xavier
    Barreau, Sylvain
    Desterke, Christophe
    Borie, Claire
    Oudrhiri, Noufissa
    Faivre, Jamila
    Bennaceur-Griscelli, A.
    Turhan, A. G.
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 692 - 695
  • [43] Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
    Quijada-Alamo, Miguel
    Perez-Carretero, Claudia
    Hernandez-Sanchez, Maria
    Rodriguez-Vicente, Ana-Eugenia
    Herrero, Ana-Belen
    Hernandez-Sanchez, Jesus-Maria
    Martin-Izquierdo, Marta
    Santos-Minguez, Sandra
    Del Rey, Monica
    Gonzalez, Teresa
    Rubio-Martinez, Araceli
    Garcia de Coca, Alfonso
    Davila-Valls, Julio
    Hernandez-Rivas, Jose-Angel
    Parker, Helen
    Strefford, Jonathan C.
    Benito, Rocio
    Ordonez, Jose-Luis
    Hernandez-Rivas, Jesus-Maria
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (02):
  • [44] THE PROGNOSTIC VALUE OF THE NUMBER OF CELLS WITH A DELETION OF 13Q14 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Zagoskina, T.
    Ovsepyan, V.
    Zotina, E.
    Baranchikova, S.
    Krinitsyna, E.
    HAEMATOLOGICA, 2013, 98 : 47 - 47
  • [45] CYTOGENETIC ABNORMALITIES DEL(17P) AND DEL(11Q) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE STUDY ON 156 YOUNG PATIENTS IN DIFFERENT PHASES OF THE DISEASE
    Del Giudice, I.
    Mauro, F. R.
    Nanni, M.
    De Propris, M. S.
    Santangelo, S.
    Marinelli, M.
    Peragine, N.
    Mancini, F.
    Armiento, D.
    Quattrocchi, L.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 217 - 217
  • [46] Genome-Wide DNA Methylation Analysis of High-Risk, Untreated Chronic Lymphocytic Leukemia (CLL) Reveals Distinct Epigenetic Profiles in Patients with Aberrations on Chromosome 17p and Chromosome 11q
    Stone, A.
    Carter, W. C.
    Frederick, L.
    Zent, C. S.
    Viswanatha, D. S.
    Schichman, S. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 663 - 663
  • [47] Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia
    Kipps, Thomas J.
    Fraser, Graeme
    Coutre, Steven E.
    Brown, Jennifer R.
    Barrientos, Jacqueline C.
    Barr, Paul M.
    Byrd, John C.
    O'Brien, Susan M.
    Dilhuydy, Marie-Sarah
    Hillmen, Peter
    Jaeger, Ulrich
    Moreno, Carol
    Cramer, Paula
    Stilgenbauer, Stephan
    Chanan-Khan, Asher A.
    Mahler, Michelle
    Salman, Mariya
    Eckert, Karl
    Solman, Isabelle G.
    Balasubramanian, Sriram
    Cheng, Mei
    Londhe, Anil
    Ninomoto, Joi
    Howes, Angela
    James, Danelle F.
    Hallek, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11): : 715 - +
  • [48] Deletion of chromosome 5q as a rare but non random abnormality in chronic lymphocytic leukemia (CLL)
    Karakosta, M.
    Korantzis, I.
    Tsakiridou, A.
    Pantelias, G.
    Sambani, C.
    Manola, K.
    CHROMOSOME RESEARCH, 2009, 17 : 125 - 125
  • [49] IgVH Mutational Status Is Prognostic In 13q Deletion (del) Chronic Lymphocytic Leukemia (CLL)
    Gladstone, Douglas Edward
    Swinnen, Lode J.
    Gocke, Christopher
    Blackford, Amanda
    Griffin, Constance A.
    Jones, Richard J.
    BLOOD, 2010, 116 (21) : 1003 - 1003
  • [50] NOTCH1, SF3B1 and BIRC3 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients Requiring First-LINE Treatment: Correlation with Biological Parameters and Response to Treatment
    Chiaretti, Sabina
    Marinelli, Marilisa
    Del Giudice, Ilaria
    Bonina, Silvia
    Gabrielli, Sara
    Piciocchi, Alfonso
    Messina, Monica
    Vignetti, Marco
    Rossi, Davide
    Di Maio, Valeria
    Mauro, Francesca Romana
    Guarini, Anna
    Gaidano, Gianluca
    Foa, Robin
    BLOOD, 2012, 120 (21)
12345